About Us
Decoding the Brain for Tomorrow’s Treatments
At Inscopix, we seek to unlock human potential by developing advanced technologies and quantitative neural circuit-based approaches to understand the brain in health and to heal it in disease.
Positioned at the intersection of neuroscience, technology, and community, we work with stakeholders across sectors- academia, biopharmaceutical industry, philanthropy, and government- to catalyze and translate deep scientific insights into new therapies for people living with debilitating neurological and psychiatric illnesses such as depression, Parkinson’s, Alzheimer’s, and PTSD.
Company Snapshot
884
LABS SERVED
2,367
SYSTEMS INSTALLED
340
CITED PUBLICATIONS
Mountain View, California
HEADQUARTERS
Recognition
In 2016, Inscopix was ranked #61 on Deloitte’s Technology Fast 500™, a ranking of the 500 fastest growing technology and media companies in North America.
In 2015, the World Economic Forum recognized Inscopix as a Technology Pioneer, an honor that it bestows on a selection of the world’s most innovative young companies.
In 2014, the White House recognized Inscopix as an industry partner of the Presidential BRAIN Initiative. Inscopix supported the initiative through its $2 million DECODE Grant Program.
In 2013, The Scientist magazine ranked Inscopix’s miniature microscope as the #1 life science innovation, calling it a “major disruptive event in the history of neuroscience.”